期刊文献+

羊水干细胞的研究现状 被引量:1

Current Status of Research on Amniotic Fluid-derived Stem Cells
原文传递
导出
摘要 由于羊水干细胞(AFSC)具有高度增殖能力、来源容易、免疫原性弱、致瘤性低、符合伦理学等独特优势,并与其它干细胞一样存在多向分化潜能,在细胞治疗或组织工程研究中展现出广阔的应用前景,使其极有望成为心血管疾病再生医学的理想种子细胞。羊水干细胞在心血管疾病中的研究尚处于起步阶段,尽管许多研究结果令人振奋,但将其应用于心血管疾病再生医学中仍面临许多挑战,在很多方面的研究亟需深入。我们总结了羊水干细胞的性质、获取羊水的时机对羊水干细胞的影响、分离纯化及鉴定方法,重点综述羊水干细胞向心血管细胞分化的潜能及在心脏组织工程中的应用现状和相关问题。 The amniotic fluid-derived stem cells(AFSC) possess considerable advantageous characteristics including high proliferation potential,easy availability,low immunogenicity and oncogenicity,and accordance with medical ethnics. Moreover,they do not require the sacrifice of human embryos for their isolation and the cells can differentiate into all three kinds of germs.Accordingly,they initiate a new and very promising field in stem cell research and they will be a potential source of stem cells for therapies related to regeneration medicine of cardiovascular diseases.The research about the AFSC utilization in cardiovascular diseases is just started.Though there were some exciting breakthroughs, there still remain many challenges.In the article,we will discuss AFSC characteristics,influence of amniotic fluid harvesting time on stem cells,isolation and purification,emphasizing mainly on the potential of AFSC differentiation into cardiovascular cells,current situation and problems in this field.
出处 《中国胸心血管外科临床杂志》 CAS 2010年第5期399-403,共5页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词 羊水干细胞 心血管疾病 再生医学 Amniotic fluid-derived stem cell Cardiovascular disease Regeneration medicine
  • 相关文献

参考文献42

  • 1Cananzi M,Atala A,De Coppi P.Stem cells derived from amniotic fluid:new potentials in regenerative medicine.Reprod Biomed Online,2009,18(Suppl 1):17-27.
  • 2Mimeault M,Hauke R,Batra SK.Stem cells:a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.Clin Pharmacol Ther,2007,82(3):252-264.
  • 3Siegel N,Rosner M,Hanneder M,et al.Human amniotic fluid stem cells:a new perspective.Amino Acids,2008,35(2):291-293.
  • 4Perin L,Sedrakyan S,Da Sacco S,et al.Characterization of human amniotic fluid stem cells and their pluripotential capability.Methods Cell Biol,2008,86(4):85-99.
  • 5De Coppi P,Bartsch G Jr,Siddiqui MM,et al.Isolation of amniotic stem cell lines with potential for therapy.Nat Biotechnol,2007,25(1):100-106.
  • 6Chen WQ,Siegel N,Li L,et al.Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25.J Proteome Res,2009,8(11):5285-5295.
  • 7Torricelli F,Brizzi L,Bernabei PA,et al.Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation.Ital J Anat Embryol,1993,98(2):119-126.
  • 8Zhang P,Baxter J,Vinod K,et al.Endothelial differentiation of amniotic fluid-derived stem cells:synergism of biochemical and shear force stimuli.Stem Cells Dev,2009,18(9):1299-1308.
  • 9Int Anker PS,Scherjon SA,Kleijburg-van der Keur C,et al.Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.Stem Cells,2004,22(7):1338-1345.
  • 10You Q,Tong X,Guan Y,et al.The biological characteristics of human third trimester amniotic fluid stem cells.J Int Med Res,2009,37(1):105-112.

二级参考文献15

  • 1Prusa AR, Marton E, Rosner M, et al. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research'?. Hum Reprod, 2003, 18(7): 1489-1493.
  • 2Paolo DC, Georg BJ, Siddiquil M, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol, 2007, 25(1): 100-106.
  • 3Tsai MS, Hwang SM, Tsai YL, et al. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod, 2006, 74(3): 545-551.
  • 4Xiang ZF, Frederike K, Jennifer C, et al. Neoplasia driven by mutant c-kit is mediated by intracellular, not plasma membrane, receptor signaling. Mol Cell Biol, 2007, 27(1): 267-282.
  • 5Martina L, Manfred M, Thomas S. Downregulation of the cellular adhesion molecule Thy- 1 (CD90) by cytomegalovirus infection of human fibroblasts. J Gen Virol, 2004, 85(7): 1995-2000.
  • 6Xu XQ, Yu ZY, Qian JQ, et al. Expression of leukocyte adhesion molecules CDllb, L-selectin and CD45 during hemodialysis. Chin MedJ, 1999, 112 (12): 1073-1076.
  • 7Kim J, Lee Y, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif, 2007, 40(1): 75-90.
  • 8Odeberg J, Plachter B, Branden L, et al. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosornes and destruction of the HLA-DR α-chain. Blood, 2003, 101(12): 4870-4877.
  • 9Ken-Ichi H, lames Y. Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen. WIPO Patent, WO 2001/ 025271, 2001-04-12.
  • 10Itskovitz-Eldorl J, Schuldiner M, Karsenti D, et al. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Molecular Medicine, 2000, 6(2): 88-95.

共引文献8

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部